SZSE:002349 (China)
Â
Class A
Â¥
7.30
(+0.27%)
Jan 16
Business Description
Jinghua Pharmaceutical Group Co Ltd
NAICS : 325411
SIC : 2833
ISIN : CNE100000L14
Share Class Description:
SZSE:002349: Class ACompare
Compare
Traded in other countries / regions
002349.China IPO Date
2010-02-03Description
Jinghua Pharmaceutical Group Co Ltd is engaged in the pharmaceutical research, development, manufacturing, and trading for active pharmaceutical ingredients, pharmaceutical intermediates, western medicines and proprietary Chinese medicine preparations. The company is also involved in the field of bio-medicine. It sells its products in China and also exports it to international countries.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 82.86 | |||||
| Equity-to-Asset | 0.79 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.05 | |||||
| Interest Coverage | 99.03 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 12.61 | |||||
| Beneish M-Score | -2.54 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.7 | |||||
| 3-Year EBITDA Growth Rate | 35.5 | |||||
| 3-Year EPS without NRI Growth Rate | 32.9 | |||||
| 3-Year FCF Growth Rate | 7.8 | |||||
| 3-Year Book Growth Rate | 6 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.74 | |||||
| 9-Day RSI | 36.74 | |||||
| 14-Day RSI | 38.72 | |||||
| 6-1 Month Momentum % | 27.38 | |||||
| 12-1 Month Momentum % | -0.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.77 | |||||
| Quick Ratio | 5.81 | |||||
| Cash Ratio | 4.37 | |||||
| Days Inventory | 149.81 | |||||
| Days Sales Outstanding | 70.12 | |||||
| Days Payable | 72.78 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.26 | |||||
| Dividend Payout Ratio | 0.34 | |||||
| Forward Dividend Yield % | 1.26 | |||||
| 5-Year Yield-on-Cost % | 1.25 | |||||
| 3-Year Average Share Buyback Ratio | 0.9 | |||||
| Shareholder Yield % | 1.23 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 49.6 | |||||
| Operating Margin % | 18.69 | |||||
| Net Margin % | 15.07 | |||||
| FCF Margin % | 17.05 | |||||
| ROE % | 8.64 | |||||
| ROA % | 6.8 | |||||
| ROIC % | 13.37 | |||||
| 3-Year ROIIC % | -30.21 | |||||
| ROC (Joel Greenblatt) % | 31.22 | |||||
| ROCE % | 10.5 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 27.55 | |||||
| PE Ratio without NRI | 27.24 | |||||
| Shiller PE Ratio | 48.67 | |||||
| Price-to-Owner-Earnings | 39.47 | |||||
| PS Ratio | 4.17 | |||||
| PB Ratio | 2.35 | |||||
| Price-to-Tangible-Book | 2.58 | |||||
| Price-to-Free-Cash-Flow | 24.54 | |||||
| Price-to-Operating-Cash-Flow | 21.62 | |||||
| EV-to-EBIT | 16.53 | |||||
| EV-to-EBITDA | 16.53 | |||||
| EV-to-Revenue | 3.46 | |||||
| EV-to-FCF | 20.02 | |||||
| Price-to-Projected-FCF | 1.58 | |||||
| Price-to-Median-PS-Value | 0.79 | |||||
| Price-to-Graham-Number | 1.77 | |||||
| Price-to-Net-Current-Asset-Value | 4.29 | |||||
| Price-to-Net-Cash | 9.13 | |||||
| Earnings Yield (Greenblatt) % | 6.05 | |||||
| FCF Yield % | 4.17 | |||||
| Forward Rate of Return (Yacktman) % | 18.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jinghua Pharmaceutical Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,437.264 | ||
| EPS (TTM) (Â¥) | 0.265 | ||
| Beta | 0.5 | ||
| Volatility % | 36.82 | ||
| 14-Day RSI | 38.72 | ||
| 14-Day ATR (Â¥) | 0.297132 | ||
| 20-Day SMA (Â¥) | 7.744 | ||
| 12-1 Month Momentum % | -0.82 | ||
| 52-Week Range (Â¥) | 5.88 - 9.34 | ||
| Shares Outstanding (Mil) | 814.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jinghua Pharmaceutical Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jinghua Pharmaceutical Group Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Jinghua Pharmaceutical Group Co Ltd Frequently Asked Questions
What is Jinghua Pharmaceutical Group Co Ltd(SZSE:002349)'s stock price today?
The current price of SZSE:002349 is ¥7.30. The 52 week high of SZSE:002349 is ¥9.34 and 52 week low is ¥5.88.
When is next earnings date of Jinghua Pharmaceutical Group Co Ltd(SZSE:002349)?
The next earnings date of Jinghua Pharmaceutical Group Co Ltd(SZSE:002349) is .
Does Jinghua Pharmaceutical Group Co Ltd(SZSE:002349) pay dividends? If so, how much?
The Dividend Yield %  of Jinghua Pharmaceutical Group Co Ltd(SZSE:002349) is 1.26% (As of Today), Highest Dividend Payout Ratio of Jinghua Pharmaceutical Group Co Ltd(SZSE:002349) was 0.4. The lowest was 0.17. And the median was 0.27. The  Forward Dividend Yield % of Jinghua Pharmaceutical Group Co Ltd(SZSE:002349) is 1.26%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers